Veracyte, Inc. 8-K Filing: Key Updates and Insights for Stakeholders
Based on the provided section of the financial report, here are the key pieces of information extracted:
- Entity Information:
- Company Name: Veracyte, Inc.
- State of Incorporation: Delaware (DE)
- CIK Number: 0001384101
- SEC File Number: 001-36156
- EIN: 20-5455398
- Address: 6000 Shoreline Court, Suite 300, South San Francisco, CA 94080
- Phone Number: 650-243-6300
- Filing Details:
- Filing Type: 8-K
- Filing Date: February 24, 2025
- Stock Information:
- Type of Security: Common Stock
- Par Value: $0.001 per share
- Ticker Symbol: VCYT
- Exchange: NASDAQ
- Period of Report:
- Start Date: February 24, 2025
- End Date: February 24, 2025
Insights:
- The report is a Form 8-K, which is typically used by publicly traded companies to announce major events that shareholders should know about.
- The filing date and the reporting period are the same, indicating that this may cover an immediate event or action taken by the company.
- Veracyte, Inc. is publicly traded on NASDAQ under the ticker VCYT, which provides insights into its market presence and potential investor interest.
- The address and contact information imply a stable operational base in South San Francisco, a region known for its biotech and life sciences companies, which may be relevant for understanding the company's strategic positioning.
This information is crucial for stakeholders looking to assess recent developments or changes within Veracyte, Inc.